Re-evaluation of the ferrous oxidation in xylenol orange assay for the measurement of plasma lipid hydroperoxides

被引:108
作者
Södergren, E
Nourooz-Zadeh, J
Berglund, L
Vessby, B
机构
[1] Uppsala Univ, Unit Geriatr, Dept Publ Hlth & Caring Sci, S-75125 Uppsala, Sweden
[2] UCL, Sch Med, Dept Med, Ctr Clin Pharmacol & Therapeut Toxicol, London W1N 8AA, England
来源
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS | 1998年 / 37卷 / 03期
关键词
lipid peroxidation; hydroperoxides; plasma; measurement; sample handling; storage;
D O I
10.1016/S0165-022X(98)00025-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The ferrous oxidation in xylenol orange version 2 (FOX2) assay coupled with triphenylphosphine has recently been employed for the measurement of total plasma hydroperoxides (ROOHs). In this study, we have evaluated sample handling and the effect of storage conditions on ROOH levels in human plasma (n = 32). Mean level of ROOHs in fresh plasma was 8.35+/-3.09 mu mol/l (range 4.03-19.5 mu mol/l). Addition of butylated hydroxytoluene (BHT) immediately after sample collection had no effect on the concentration of ROOHs. Storage of samples at - 70 degrees C for 6 weeks was associated with a variable degree of loss of detectable ROOHs. A mean POOH level of 6.00+/-2.23 mu mol/l (range 2.88-13.5 mu mol/l) was;recorded after 6 weeks of storage at - 70 degrees C. There was no difference in the mean level of ROOHs between samples stored for 6 and 60 weeks at - 70 degrees C. Inclusion of BHT had no effect on the stability of plasma ROOHs during prolonged storage. Intra-assay coefficients of variation were < 12%, with the lowest variation in fresh samples (7.6%). In conclusion, these results suggest that the FOX2 assay should be a useful tool for measurement of ROOHs in fresh plasma samples but not in stored samples. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 39 条
[1]   LIPID-PEROXIDATION IN HYPERLIPEMIC PATIENTS - A STUDY OF PLASMA USING AN HPLC-BASED THIOBARBITURIC ACID TEST [J].
CHIRICO, S ;
SMITH, C ;
MARCHANT, C ;
MITCHINSON, MJ ;
HALLIWELL, B .
FREE RADICAL RESEARCH COMMUNICATIONS, 1993, 19 (01) :51-57
[2]  
CHIRICO S, 1994, METHOD ENZYMOL, V233, P314
[3]   DETECTION OF FREE-RADICALS AND CHOLESTEROL HYDROPEROXIDES IN BLOOD TAKEN FROM THE CORONARY SINUS OF MAN DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
COGHLAN, JG ;
FLITTER, WD ;
HOLLEY, AE ;
NORELL, M ;
MITCHELL, AG ;
ILSLEY, CD ;
SLATER, TF .
FREE RADICAL RESEARCH COMMUNICATIONS, 1991, 14 (5-6) :409-417
[4]  
CORONGIU FP, 1994, METHOD ENZYMOL, V233, P303
[5]   IODOMETRIC MEASUREMENT OF LIPID HYDROPEROXIDES IN HUMAN PLASMA [J].
CRAMER, GL ;
MILLER, JF ;
PENDLETON, RB ;
LANDS, WEM .
ANALYTICAL BIOCHEMISTRY, 1991, 193 (02) :204-211
[6]   LOW-DENSITY-LIPOPROTEIN COMPOSITION AND OXIDIZABILITY IN CORONARY-DISEASE - APPARENT FAVORABLE EFFECT OF BETA-BLOCKERS [J].
CROFT, KD ;
DIMMITT, SB ;
MOULTON, C ;
BEILIN, LJ .
ATHEROSCLEROSIS, 1992, 97 (2-3) :123-130
[7]   A COMPARATIVE-EVALUATION OF THIOBARBITURIC ACID METHODS FOR THE DETERMINATION OF MALONDIALDEHYDE IN BIOLOGICAL-MATERIALS [J].
DRAPER, HH ;
SQUIRES, EJ ;
MAHMOODI, H ;
WU, J ;
AGARWAL, S ;
HADLEY, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (04) :353-363
[8]  
DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
[9]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[10]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75